Literature DB >> 17476550

Evaluation of lipophilic antioxidant efficacy in vivo by the biomarkers hydroxyoctadecadienoic acid and isoprostane.

Yasukazu Yoshida1, Mieko Hayakawa, Yoko Habuchi, Nanako Itoh, Etsuo Niki.   

Abstract

The evaluation of antioxidant activity in vivo is difficult. In this study, the effects of dietary natural and synthetic antioxidants on the lipid peroxidation in mice were assessed using a biomarker, total hydroxyoctadecadienoic acid (tHODE). Biological samples such as plasma, erythrocytes, and tissues were first reduced and then saponified to convert various oxidation products of linoleates to tHODE. Subsequently, the absolute concentration of tHODE and its stereoisomer ratio, [9- and 13-(Z,E)-HODE)/[9- and 13-(E,E)-HODE], which is a measure of the hydrogen donor capacity of antioxidants, were determined by gas chromatography-mass spectrometry (GC-MS) analyses. These were then compared with total 8-iso-prostaglandin F(2alpha) (t8-iso-PGF(2alpha)) which was also assessed after reduction and saponification. Remarkable increases in tHODE and t8-iso-PGF(2alpha) levels were observed in the plasma, erythrocytes, liver, and brain of mice that were fed an alpha-tocopherol (alphaT)-stripped (E-free) diet for 1 month when compared with those of mice that were fed a standard diet (alphaT = 0.002 wt%). When mice were fed for 1 month on an E-free diet supplemented with a lipophilic antioxidant (0.04 wt%), namely, alphaT, alpha-tocotrienol (alphaT3), gamma-tocopherol (gammaT), or 2,3-dihydro-5-hydroxy-4,6-di-tert-butyl-2,2-dipentylbenzofuran (BO-653), a potent synthetic antioxidant, the increases of tHODE and t8-iso-PGF(2alpha) in the plasma, erythrocytes, liver, and brain were suppressed to the levels lower than those of mice fed a standard diet. The (Z,E/E,E) HODE ratio was decreased in the plasma and erythrocytes of mice fed the E-free diet when compared with that in mice fed the standard diet. This stereo-isomeric ratio was significantly recovered by the addition of alphaT and BO-653. These results show that the tHODE level and the (Z,E/E,E) HODE ratio are useful biomarkers for the assessment of antioxidant capacity in vivo and that the antioxidant capacity decreased in the order: BO-653 > alphaT3 >or= alphaT, gammaT, as assessed by tHODE levels from blood, liver, and brain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17476550     DOI: 10.1007/s11745-007-3043-7

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.646


  26 in total

1.  Kinetic products of linoleate peroxidation: rapid beta-fragmentation of nonconjugated peroxyls.

Authors:  K A Tallman; D A Pratt; N A Porter
Journal:  J Am Chem Soc       Date:  2001-11-28       Impact factor: 15.419

2.  Peroxyl radical clocks.

Authors:  Bill Roschek; Keri A Tallman; Christopher L Rector; Jason G Gillmore; Derek A Pratt; Carlo Punta; Ned A Porter
Journal:  J Org Chem       Date:  2006-04-28       Impact factor: 4.354

3.  Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress.

Authors:  S Yamashita; Y Yamamoto
Journal:  Anal Biochem       Date:  1997-07-15       Impact factor: 3.365

4.  Oxidation of low density lipoprotein and plasma by 15-lipoxygenase and free radicals.

Authors:  H Yamashita; A Nakamura; N Noguchi; E Niki; H Kühn
Journal:  FEBS Lett       Date:  1999-02-26       Impact factor: 4.124

5.  Evaluation of the dietary effects of coenzyme Q in vivo by the oxidative stress marker, hydroxyoctadecadienoic acid and its stereoisomer ratio.

Authors:  Yasukazu Yoshida; Mieko Hayakawa; Yoko Habuchi; Etsuo Niki
Journal:  Biochim Biophys Acta       Date:  2006-06-27

6.  Detection of lipid peroxidation in vivo: total hydroxyoctadecadienoic acid and 7-hydroxycholesterol as oxidative stress marker.

Authors:  Yasukazu Yoshida; Etsuo Niki
Journal:  Free Radic Res       Date:  2004-08

7.  Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration.

Authors:  Savita Khanna; Sashwati Roy; Hoon Ryu; Praveen Bahadduri; Peter W Swaan; Rajiv R Ratan; Chandan K Sen
Journal:  J Biol Chem       Date:  2003-08-13       Impact factor: 5.157

8.  Comparative study on the action of tocopherols and tocotrienols as antioxidant: chemical and physical effects.

Authors:  Yasukazu Yoshida; Etsuo Niki; Noriko Noguchi
Journal:  Chem Phys Lipids       Date:  2003-03       Impact factor: 3.329

Review 9.  F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases.

Authors:  Domenico Praticò; Joshua Rokach; John Lawson; Garret A FitzGerald
Journal:  Chem Phys Lipids       Date:  2004-03       Impact factor: 3.329

10.  Inhibition of plasma lipid peroxidation by anti-atherogenic antioxidant BO-653, 2,3-dihydro-5-hydroxy-4,6-di-tert-butyl-2,2-dipentylbenzofuran.

Authors:  Nanako Itoh; Yasukazu Yoshida; Mieko Hayakawa; Noriko Noguchi; Tatsuhiko Kodama; Osamu Cynshi; Etsuo Niki
Journal:  Biochem Pharmacol       Date:  2004-09-01       Impact factor: 5.858

View more
  10 in total

1.  Ex vivo oxidation in tissue and plasma assays of hydroxyoctadecadienoates: Z,E/E,E stereoisomer ratios.

Authors:  Wei Liu; Huiyong Yin; Yoko Ogawa Akazawa; Yasukazu Yoshida; Etsuo Niki; Ned A Porter
Journal:  Chem Res Toxicol       Date:  2010-05-17       Impact factor: 3.739

Review 2.  Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases.

Authors:  Bharat B Aggarwal; Chitra Sundaram; Seema Prasad; Ramaswamy Kannappan
Journal:  Biochem Pharmacol       Date:  2010-08-07       Impact factor: 5.858

3.  Supplementation with lutein or lutein plus green tea extracts does not change oxidative stress in adequately nourished older adults.

Authors:  Lei Li; C-Y Oliver Chen; Giancarlo Aldini; Elizabeth J Johnson; Helen Rasmussen; Yasukazu Yoshida; Etsuo Niki; Jeffrey B Blumberg; Robert M Russell; Kyung-Jin Yeum
Journal:  J Nutr Biochem       Date:  2009-05-15       Impact factor: 6.048

4.  Physiological response to lipid peroxidation in ischemia and reperfusion during carotid endarterectomy.

Authors:  Sebastiano Banni; Roberto Montisci; Roberto Sanfilippo; Gabriele Finco; Daniela Sanna; Elena Giordano; Elisabetta Murru; Lina Cordeddu; Gianfranca Carta; Donata Banni; Antonio Marchi
Journal:  Lipids Health Dis       Date:  2010-04-21       Impact factor: 3.876

Review 5.  Vitamin E and nonalcoholic fatty liver disease.

Authors:  Tommy Pacana; Arun J Sanyal
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-11       Impact factor: 4.294

6.  Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method.

Authors:  Wei Liu; Jason D Morrow; Huiyong Yin
Journal:  Free Radic Biol Med       Date:  2009-07-30       Impact factor: 7.376

7.  Effect of acute administration of Pistacia lentiscus L. essential oil on rat cerebral cortex following transient bilateral common carotid artery occlusion.

Authors:  Marina Quartu; Maria P Serra; Marianna Boi; Giuliano Pillolla; Tiziana Melis; Laura Poddighe; Marina Del Fiacco; Danilo Falconieri; Gianfranca Carta; Elisabetta Murru; Lina Cordeddu; Antonio Piras; Maria Collu; Sebastiano Banni
Journal:  Lipids Health Dis       Date:  2012-01-12       Impact factor: 3.876

Review 8.  Pharmacological potential of tocotrienols: a review.

Authors:  Haseeb Ahsan; Amjid Ahad; Jahangir Iqbal; Waseem A Siddiqui
Journal:  Nutr Metab (Lond)       Date:  2014-11-12       Impact factor: 4.169

9.  Lipid peroxidation biomarkers for evaluating oxidative stress and assessing antioxidant capacity in vivo.

Authors:  Yasukazu Yoshida; Aya Umeno; Mototada Shichiri
Journal:  J Clin Biochem Nutr       Date:  2012-12-06       Impact factor: 3.114

10.  Opposing effects of oxidative challenge and carotenoids on antioxidant status and condition-dependent sexual signalling.

Authors:  Oldřich Tomášek; Barbora Gabrielová; Petr Kačer; Petr Maršík; Jana Svobodová; Kamila Syslová; Michal Vinkler; Tomáš Albrecht
Journal:  Sci Rep       Date:  2016-03-22       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.